Percutaneous radiofrequency ablation therapy for recurrent hepatocellular carcinoma
H Nishikawa, Y Osaki, E Iguchi, H Takeda… - Anticancer …, 2012 - ar.iiarjournals.org
Aim: To compare the overall survival (OS) in patients without recurrent hepatocellular
carcinoma (HCC) after initial radiofrequency ablation (RFA) and in those with recurrence …
carcinoma (HCC) after initial radiofrequency ablation (RFA) and in those with recurrence …
Repeated stereotactic body radiation therapy for hepatocellular carcinoma
T Eriguchi, N Tsukamoto, N Kuroiwa, T Nemoto… - Practical Radiation …, 2021 - Elsevier
Purpose In clinical practice, whether cirrhotic livers in patients with hepatocellular carcinoma
(HCC) can withstand repeated stereotactic body radiation therapy (SBRT) remains unclear …
(HCC) can withstand repeated stereotactic body radiation therapy (SBRT) remains unclear …
[HTML][HTML] Clinical Outcomes of Next-Generation Microwave Thermosphere Ablation for Hepatocellular Carcinoma with Primarily Hepatitis-Related Etiology
S Nakamura, T Tada, M Sue, Y Matsuo… - Journal of Clinical …, 2023 - mdpi.com
Background and aim: We investigated the clinical outcomes of patients with hepatocellular
carcinoma (HCC) who underwent next-generation microwave thermosphere ablation (MTA) …
carcinoma (HCC) who underwent next-generation microwave thermosphere ablation (MTA) …
Radiofrequency ablation of metastatic lesions from breast cancer
C Bortolotto, S Macchi, L Veronese, R Dore… - Journal of ultrasound, 2012 - Elsevier
INTRODUCTION: Breast cancer (BC) is the most common malignancy in women. Various
studies [5, 6] have shown that surgical resection of single liver or lung metastases in patients …
studies [5, 6] have shown that surgical resection of single liver or lung metastases in patients …
Long-term survival in patients receiving combination therapy with resection and radiofrequency ablation for multi-focal hepatocellular carcinoma classified as …
J Yan, Z Man, Q Lu, K Ma - Cancer Management and Research, 2020 - Taylor & Francis
Objective To evaluate the survival outcomes of combined liver resection (LR) and
radiofrequency ablation (RFA) on multi-focal hepatocellular carcinoma (HCC) in patients …
radiofrequency ablation (RFA) on multi-focal hepatocellular carcinoma (HCC) in patients …
肝癌射频消融治疗的临床研究进展
陈敏山， 徐立， 彭振维 - 外科理论与实践, 2012 - qk.sjtu.edu.cn
肝癌的治疗模式已由过去的单一外科切除转变为以外科切除为主的多手段,
多学科综合治疗模式. 在多种治疗方法中, 以射频消融(radiofrequen-cy ablation, RFA) …
多学科综合治疗模式. 在多种治疗方法中, 以射频消融(radiofrequen-cy ablation, RFA) …
Stereotactic body radiotherapy as a salvage therapy after incomplete radiofrequency ablation for hepatocellular carcinoma: A retrospective cohort study
Y Fu, M Xi, Y Pan, J Chen, J Wang, S Liu… - Journal of …, 2020 - Wiley Online Library
Residual tumor tissue after radiofrequency ablation (RFA) is inevitable in clinical practice,
and the optimal management of residual tumor after RFA has not been established. To …
and the optimal management of residual tumor after RFA has not been established. To …
[HTML][HTML] Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0–B1 …
F Wang, K Numata, A Takeda, K Ogushi, H Fukuda… - PloS one, 2021 - journals.plos.org
Aim To evaluate the safety and efficacy of the administration of radiofrequency ablation
(RFA) and stereotactic body radiotherapy (SBRT) in the short term to the same patients in …
(RFA) and stereotactic body radiotherapy (SBRT) in the short term to the same patients in …